Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen in Gram Positive Cocci Endocarditis
NCT04691440Phase 2Unknown
- Sponsor
- Ole Hyldegaard
- Start
- Dec 2019
- Primary completion
- Jul 2021
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
A Phase 2 trial of hyperbaric oxygen therapy in infective endocarditis (IE), sponsored by Ole Hyldegaard. Status: unknown.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
infective endocarditis (IE)
Beyond the preview
Go deeper on NCT04691440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04691440.